Hemodialysis and Peritoneal Dialysis Market Share, Size and Growth Analysis By 2029

The global market for hemodialysis and peritoneal dialysis is anticipated to grow significantly, reaching approximately US$ 130,370.18 million by 2028, up from US$ 84,610.62 million in 2021. This growth represents a compound annual growth rate (CAGR) of 6.4% from 2022 to 2028.

The increasing incidence of diabetes and kidney diseases is a major factor propelling the market's expansion. Additionally, the competitive landscape is characterized by numerous market players who are launching innovative products and services, which is expected to shape future trends in the hemodialysis and peritoneal dialysis sectors.

According to a report from the Clinical Journal of the American Society of Nephrology, around 40% of individuals with diabetes develop diabetic kidney disease, which is a leading cause of chronic kidney disease (CKD) worldwide. CKD occurs when the kidneys can no longer maintain a healthy state for patients, necessitating dialysis or transplantation when kidney function drops to 10-15%.

The International Diabetes Federation reported that in 2021, approximately 537 million adults aged between 29 and 70 were living with diabetes, with projections indicating this number could rise to 643 million by 2030 and 783 million by 2045. In the United States, the Centers for Disease Control and Prevention (CDC) noted that over 34 million Americans had diabetes in 2020, accounting for nearly 11% of the population. The American Diabetes Association (ADA) also highlighted that around 1.5 million new diabetes cases are diagnosed annually.

In Europe, the World Health Organization estimates that about 60 million individuals have diabetes, with prevalence rates of 10.3% among men and 9.6% among women aged 25 and older. The condition is particularly common among older adults, with approximately 19.3 million people aged 60-79 affected, compared to 11.3 million aged 40-59 and only 1.7 million aged 20-39.

Diabetes can damage small blood vessels throughout the body, including those in the kidneys, impairing their ability to filter blood effectively. This can lead to fluid retention, weight gain, and swelling, as well as the accumulation of waste products in the bloodstream. Furthermore, nerve damage caused by diabetes can hinder bladder function, increasing pressure on the kidneys. Studies indicate that approximately 30% of patients with Type 1 diabetes and 10-40% of those with Type 2 diabetes may eventually experience kidney failure, driving the demand for dialysis treatments and contributing to the growth of the hemodialysis and peritoneal dialysis market.

The market is categorized by type, product, and end user. In terms of products, it is divided into devices, consumables, and services. The services segment is projected to dominate the market share from 2022 to 2028, while the consumables segment is expected to exhibit the highest CAGR during the forecast period. For instance, the dialysis center at the Mayo Clinic in Florida is recognized for its high-quality, patient-centered care, boasting a 5-star rating from the Centers for Medicare & Medicaid Services (CMS). It features 24 private dialysis stations, 3 home training rooms, and 2 exam rooms, along with centrally located nursing stations.

Consumables used in hemodialysis include dialyzers, AV tubing sets, fistula needles, sodium bicarbonate cartridges, and disinfectants. The growing demand for dialysis therapy is driving the consumption of these products, as they ensure patient safety. For example, B. Braun's dialysis system offers components that are tailored for effective and patient-friendly treatment.

Guidelines from the International Society of Nephrology emphasize the importance of selecting appropriate dialysis machines based on local conditions and ensuring the availability of consumables and technical support. The International Finance Corporation has noted that hospitals are implementing strategies to manage their consumable orders effectively, such as bulk purchasing to reduce costs. For instance, NephroPlus managed to negotiate lower prices by buying in bulk, which also facilitated better resource distribution and minimized waste.

Looking ahead, the hemodialysis and peritoneal dialysis market is marked by both large and small companies striving to enhance their market presence through product launches, regional expansions, and technological innovations. Continuous advancements are leading to the development of safer and more effective dialysis options, which are gaining acceptance among patients and healthcare professionals alike. For example, in November 2021, Fresenius Medical Care introduced advanced home dialysis solutions at the China International Import Expo, showcasing new digitalized options for patients with end-stage renal disease (ESRD).

Moreover, in March 2021, Baxter International Inc. received FDA clearance for its next-generation Artificial Kidney 98 (AK 98) dialysis machine, designed for portability and ease of use. This machine features an encrypted bidirectional connection that allows it to directly access prescriptions from electronic medical records, streamlining workflows.

These developments are expected to significantly contribute to the growth of the hemodialysis and peritoneal dialysis market in the coming years. Key sources for this report include the American Diabetes Association, the Indian Council of Medical Research, the CDC, the FDA, the Canadian Medical Association, and the Japanese Society for Dialysis Therapy.